Evidence map›Paper›PMID 27153921›Full record

ArticleJournal of the American Society of Nephrology : JASN2016

Small-Molecule Inhibitors of Pendrin Potentiate the Diuretic Action of Furosemide.

Onur Cil, Peter M Haggie, Puay-Wah Phuan, Joseph-Anthony Tan, Alan S Verkman

Abstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Repurposing approved drugs as Pendrin (Frontiers in pharmacology · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Pendrin: linking acid base to blood pressure.Pflugers Archiv : European journal of physiology · 2024
    Review
  10. Article
  11. SLC26 Anion Transporters.Handbook of experimental pharmacology · 2024
    Review
  12. Article
  13. Cross-species applicability of an adverse outcome pathway network for thyroid hormone system disruption.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Review
  14. Article
  15. New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022.European heart journal. Cardiovascular pharmacotherapy · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Chloride transport modulators as drug candidates.American journal of physiology. Cell physiology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Onur CilDepartments of Medicine and Physiology, University of California San Francisco, San Francisco, California.
Peter M HaggieDepartments of Medicine and Physiology, University of California San Francisco, San Francisco, California.
Puay-Wah PhuanDepartments of Medicine and Physiology, University of California San Francisco, San Francisco, California.
Joseph-Anthony TanDepartments of Medicine and Physiology, University of California San Francisco, San Francisco, California.
Alan S VerkmanDepartments of Medicine and Physiology, University of California San Francisco, San Francisco, California Alan.Verkman@ucsf.edu.
University of California, San Francisco · US

Funding

SynthesisP30DK072517 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VERKMAN, ALAN S · 2005 to 2022
$18.1M
Translational Research Enhancement CoreP30DK089502 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI ZACHOS, NICHOLAS CONSTANTINE · 2011 to 2020
$12.0M
Translational Approaches to Develop Drug Therapy for DiarrheaR24DK099803 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI DONOWITZ, MARK · 2014 to 2019
$8.9M
Functional Role of Aquaporins in Eye PhysiologyR01EY013574 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VERKMAN, ALAN S · 2002 to 2022
$7.6M
MECHANISMS OF WATER TRANSPORT IN RENAL EPITHELIAR37DK035124 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VERKMAN, ALAN S · 1999 to 2008
$4.2M
Application of Novel Optical Methods to Cell DynamicsR37EB000415 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VERKMAN, ALAN S · 2007 to 2016
$4.1M
Urea transport inhibitors as a new class of diureticsR01DK101373 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VERKMAN, ALAN S · 2014 to 2018
$1.7M
Application of Novel Optical Methods to Cell DynamicsR01EB000415 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VERKMAN, ALAN S · 2002 to 2006
$1.7M
WATER AND NON-ELECTROLYTE TRANSPORT IN RENAL VESICLESR01DK035124 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VERKMAN, ALAN S · 1986 to 2014
$1.4M
NEI NIH HHS R01 EY013574NIBIB NIH HHS R01 EB000415NIBIB NIH HHS R37 EB000415NIDDK NIH HHS P30 DK072517NIDDK NIH HHS P30 DK089502NIDDK NIH HHS R01 DK035124NIDDK NIH HHS R01 DK101373NIDDK NIH HHS R24 DK099803NIDDK NIH HHS R37 DK035124
6 · The paper itself

Abstract

Pendrin is a Cl

Indexed as

AnimalsAnion Transport ProteinsDiureticsDrug SynergismFemaleFurosemideMiceSulfate TransportersSulfonamidesThiophenesAnion Transport ProteinsDiureticsFurosemidePDS(inh)-C01Slc26a4 protein, mouseSulfate TransportersSulfonamidesThiophenescell & transport physiologycollecting ductsdiureticswater-electrolyte balance

Identifiers

PMID27153921
PMCPMC5118489
OpenAlexW2345738618

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.